Statistics from Altmetric.com
Antibodies directed against contactin-associated protein-like 2 (CASPR2) have been identified in the sera of patients with peripheral and central neurological syndromes, including neuromyotonia, Morvan syndrome (MoS) and autoimmune limbic encephalitis (LE).1 MoS is characterised by peripheral nervous hyperactivity, autonomic dysfunction and LE. Electrocardiac abnormalities, mostly sinus tachycardia, are manifestation of cardiac autonomic dysfunction in patients with MoS.2 Here we describe our observation that electrocardiac abnormalities may present with high prevalence and evolve with the disease courses in CASPR2 antibody (Ab)-positive MoS.
We observed severe arrhythmia and cardiac arrest in one patient with CASPR2 Ab-positive MoS and subsequently conducted a retrospective analysis of hospitalised patients with anti-CASPR2 Ab-associated neurological disorders between November 2014 and January 2017 at Peking Union Medical College Hospital. Samples were tested using brain immunohistochemistry and cell-based assays in parallel for the determination of anti-CASPR2 Abs and other antibodies (including anti-N-methyl D-aspartate (NMDA) receptor, LGI1, GABAA receptor and GABAB receptor). Patients were considered to have anti-CASPR2 Abs if both tests were recorded as strongly positive in either of the samples. Written informed consent was obtained from all the patients or their supervisors due to psychiatric and cognitive malfunctions.
A 58-year-old man presented with insomnia and sleepwalking for 2 years. One month before admission to our hospital, he complained of aches all over the body and developed visual and auditory hallucinations, urinary retention, constipation and weight loss (8 kg). The symptoms worsened with episodic anxiety and agitation, accompanied by muscle cramps. On physical …
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.